CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs)
Advances in induced pluripotent stem cell (iPSC) technology provide a renewable source of cells for tissue regeneration and therefore hold great promise for cell replacement therapy. However, immune rejection of allograft due to human leukocyte antigen (HLA) mismatching remains a major challenge. Co...
Saved in:
Main Author: | Thongsin N. |
---|---|
Other Authors: | Mahidol University |
Format: | Book Chapter |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/83902 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs)
by: Nontaphat Thongsin, et al.
Published: (2022) -
Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9
by: Methichit Wattanapanitch
Published: (2022) -
Generation of B2M bi-allelic knockout human induced pluripotent stem cells (MUSIi001-A-1) using a CRISPR/Cas9 system
by: Nontaphat Thongsin, et al.
Published: (2022) -
One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
by: Methichit Wattanapanitch, et al.
Published: (2019) -
Scaffold-based delivery of CRISPR/Cas9 ribonucleoproteins for genome editing
by: Chooi, Wai Hon, et al.
Published: (2021)